Pharmaceutical News

RSS

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.

19 Feb 2021

Could measles virus vectors be used for a new COVID-19 vaccine?

A research team at the Institut Pasteur in France describes the successful development of such a vaccine utilizing a measles virus vector.

18 Feb 2021

How has 3D printing come to the aid of healthcare during the COVID-19 pandemic?

In the study, published in the journal Emergent Materials, the researchers identified the role of 3D printing in COVID-19. During the pandemic, over 100 various 3D printable PPE designs have been used.

18 Feb 2021

Tuberculosis vaccine could protect newborns against common infections

The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in The Lancet Infectious Diseases.

18 Feb 2021

Simulated model for drive-through clinics can be used for mass COVID-19 vaccinations

Policymakers at all levels of government are racing to vaccinate hundreds of millions of people to save lives and blunt the deadly COVID-19 pandemic.

18 Feb 2021

New automated system may reduce opioid misuse

After more than 1,000 orthopedic procedures at a city health system, roughly 61 percent of the opioids prescribed to patients went unused, according to new research.

18 Feb 2021

Rebate systems may hamper patient access to drugs

Pharmaceutical manufacturers and national authorities often negotiate secret rebates when determining drug prices. A UZH study shows that these rebate systems may hamper patient access to drugs. In the medium term, this practice can even lead to increasing drug prices.

17 Feb 2021

$Study investigates fracture-associated drug use among long-term care residents$

Study investigates fracture-associated drug use among long-term care residents

Findings from a new Geisel-led study, published in the Journal of General Internal Medicine, reveal that there is substantial variation across different regions of the country in the intensity of fracture-associated drug (FAD) use among long-term care facility residents, and that areas with greater use of these prescription drugs experience higher hip fracture rates.

17 Feb 2021

Study: Body produces large amounts of GDF15 hormone during extended bouts of vigorous exercise

A drug that helps us to eat less could help the more than 650 million people around the world who live with obesity.

17 Feb 2021

Rich nations should not engage in "vaccine nationalism”, says Binghamton University expert

Rich nations should not engage in "vaccine nationalism" and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York. Hassoun's paper, "Against Vaccine Nationalism," was published in the Journal of Medical Ethics.

17 Feb 2021

Pan-coronavirus vaccine needed to deal SARS-CoV-2 variants

In an article, published on the JAMA Network and written by health experts, including Dr. Anthony Fauci, American physician-scientist and immunologist serving as the director of the National Institute of Allergy and Infectious Diseases, the authors discuss the need for a pan-coronavirus vaccine, which can protect against most or all variants of SARS-CoV-2.

16 Feb 2021

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Why do patients who receive antipsychotic medications to manage schizophrenia and bipolar disorder quickly gain weight and develop prediabetes and hyperinsulemia?

15 Feb 2021

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.

15 Feb 2021

Can Pfizer and Moderna end the pandemic by sharing their vaccine designs? It’s not that simple

Vaccine makers Pfizer and Moderna earned praise for creating highly effective covid-19 vaccines in record time.

15 Feb 2021

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

When the Covid-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare.

15 Feb 2021

Immunomodulatory drugs improve the success rate of cancer therapies

Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.

15 Feb 2021

Study: Aspirin should be favored to prevent blood clots in children after complex heart surgery

Aspirin should be favored over warfarin to prevent blood clotting in children who undergo a surgery that replumbs their hearts, according to a new study.

14 Feb 2021

Poor and terminally ill Mexicans have less chance to get opioids intended for palliative care

If you're poor and terminally ill in southern Mexico, there's far less chance you'll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico-U.S. border, say UCLA researchers and colleagues who studied opioid dispensing levels across the country.

13 Feb 2021

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.

13 Feb 2021

How effective has the COVID-19 vaccination program been in Israel?

Using publicly available coronavirus disease 2019 (COVID-19) data from Israel, a study suggests the BioNTech-Pfizer BNT162b2 vaccine is proving highly effective in the real world.

12 Feb 2021

Pharmaceutical News

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Could measles virus vectors be used for a new COVID-19 vaccine?

How has 3D printing come to the aid of healthcare during the COVID-19 pandemic?

Tuberculosis vaccine could protect newborns against common infections

Simulated model for drive-through clinics can be used for mass COVID-19 vaccinations

New automated system may reduce opioid misuse

Rebate systems may hamper patient access to drugs

Study investigates fracture-associated drug use among long-term care residents

Study: Body produces large amounts of GDF15 hormone during extended bouts of vigorous exercise

Rich nations should not engage in "vaccine nationalism”, says Binghamton University expert

Pan-coronavirus vaccine needed to deal SARS-CoV-2 variants

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Study: Cytoglobin drug could delay the progression of liver fibrosis in mice

Can Pfizer and Moderna end the pandemic by sharing their vaccine designs? It’s not that simple

A machine learning approach to identify drugs that could be repurposed to fight COVID-19

Immunomodulatory drugs improve the success rate of cancer therapies

Study: Aspirin should be favored to prevent blood clots in children after complex heart surgery

Poor and terminally ill Mexicans have less chance to get opioids intended for palliative care

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

How effective has the COVID-19 vaccination program been in Israel?

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News